HEADER HYDROLASE 09-APR-07 2PGL TITLE CATALYSIS ASSOCIATED CONFORMATIONAL CHANGES REVEALED BY HUMAN CD38 TITLE 2 COMPLEXED WITH A NON-HYDROLYZABLE SUBSTRATE ANALOG COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADP-RIBOSYL CYCLASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: EXTRACELLULAR DOMAIN, RESIDUES 45-300; COMPND 5 SYNONYM: CYCLIC ADP-RIBOSE HYDROLASE 1, CADPR HYDROLASE 1, LYMPHOCYTE COMPND 6 DIFFERENTIATION ANTIGEN CD38, T10, ACUTE LYMPHOBLASTIC LEUKEMIA CELLS COMPND 7 ANTIGEN CD38; COMPND 8 EC: 3.2.2.5; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CD38; SOURCE 6 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: X-33; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPICZAA KEYWDS HUMAN CD38 E226Q MUTANT BOUND WITH N1-CIDPR, THE CATALYTIC POCKET, KEYWDS 2 CONFORMATIONAL CHANGES OF THE ACTIVE SITE, SUBSTRATE ANALOG BINDING, KEYWDS 3 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR Q.LIU,I.A.KRIKSUNOV,C.MOREAU,R.GRAEFF,B.V.L.POTTER,H.C.LEE,Q.HAO REVDAT 8 20-NOV-24 2PGL 1 REMARK REVDAT 7 30-AUG-23 2PGL 1 REMARK REVDAT 6 20-OCT-21 2PGL 1 REMARK SEQADV REVDAT 5 13-JUL-11 2PGL 1 VERSN REVDAT 4 21-JUL-09 2PGL 1 FORMUL REVDAT 3 24-FEB-09 2PGL 1 VERSN REVDAT 2 04-SEP-07 2PGL 1 JRNL REVDAT 1 24-APR-07 2PGL 0 JRNL AUTH Q.LIU,I.A.KRIKSUNOV,C.MOREAU,R.GRAEFF,B.V.POTTER,H.C.LEE, JRNL AUTH 2 Q.HAO JRNL TITL CATALYSIS-ASSOCIATED CONFORMATIONAL CHANGES REVEALED BY JRNL TITL 2 HUMAN CD38 COMPLEXED WITH A NON-HYDROLYZABLE SUBSTRATE JRNL TITL 3 ANALOG JRNL REF J.BIOL.CHEM. V. 282 24825 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17591784 JRNL DOI 10.1074/JBC.M701653200 REMARK 2 REMARK 2 RESOLUTION. 1.76 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.3.0021 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.76 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 3 NUMBER OF REFLECTIONS : 48827 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2561 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.76 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.80 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3042 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 81.62 REMARK 3 BIN R VALUE (WORKING SET) : 0.2940 REMARK 3 BIN FREE R VALUE SET COUNT : 174 REMARK 3 BIN FREE R VALUE : 0.2860 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4100 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 385 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.25 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.87000 REMARK 3 B22 (A**2) : 0.59000 REMARK 3 B33 (A**2) : 1.06000 REMARK 3 B12 (A**2) : 0.67000 REMARK 3 B13 (A**2) : 0.59000 REMARK 3 B23 (A**2) : 1.14000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.146 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.135 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.116 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.318 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4253 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5778 ; 1.415 ; 1.944 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 502 ; 5.761 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 208 ;35.975 ;24.038 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 742 ;15.945 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;17.603 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 618 ; 0.095 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3222 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1936 ; 0.221 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2872 ; 0.310 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 333 ; 0.171 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 77 ; 0.177 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 23 ; 0.184 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2581 ; 0.877 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4114 ; 1.463 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1920 ; 2.340 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1664 ; 3.708 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2PGL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-APR-07. REMARK 100 THE DEPOSITION ID IS D_1000042353. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAY-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : A1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51667 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.07100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.54700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.870 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2O3T REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES, PH 6.0, AND 15% PEG 4000, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 300K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THERE ARE TWO BIOLOGICAL UNITS IN THE CRYSTALLOGRAPHIC REMARK 300 ASYMMETRIC UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 39 REMARK 465 ARG A 40 REMARK 465 GLU A 41 REMARK 465 ALA A 42 REMARK 465 GLU A 43 REMARK 465 ALA A 44 REMARK 465 THR A 297 REMARK 465 SER A 298 REMARK 465 GLU A 299 REMARK 465 ILE A 300 REMARK 465 LYS B 39 REMARK 465 ARG B 40 REMARK 465 GLU B 41 REMARK 465 ALA B 42 REMARK 465 GLU B 43 REMARK 465 ALA B 44 REMARK 465 THR B 297 REMARK 465 SER B 298 REMARK 465 GLU B 299 REMARK 465 ILE B 300 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 128 46.87 -150.16 REMARK 500 GLN A 139 23.49 -156.57 REMARK 500 ASP A 179 -67.54 -106.16 REMARK 500 ASN A 182 50.26 -92.15 REMARK 500 ASP A 202 -122.35 65.79 REMARK 500 GLU A 248 -72.15 -110.12 REMARK 500 GLU A 292 35.68 -80.11 REMARK 500 SER B 95 -9.00 77.23 REMARK 500 ARG B 127 -38.81 69.75 REMARK 500 ILE B 128 53.75 -91.44 REMARK 500 VAL B 138 -60.06 -104.06 REMARK 500 ASP B 179 -78.58 -104.46 REMARK 500 ASP B 202 -121.12 62.10 REMARK 500 ARG B 247 -145.54 -71.47 REMARK 500 GLU B 248 -76.50 -76.69 REMARK 500 ARG B 269 6.11 -66.99 REMARK 500 GLU B 292 106.94 -50.57 REMARK 500 ASP B 293 -37.40 -171.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE N1C A 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2PGJ RELATED DB: PDB REMARK 900 WILD-TYPE HUMAN CD38 COMPLEXED WITH N1-CIDPR DBREF 2PGL A 45 300 UNP P28907 CD38_HUMAN 45 300 DBREF 2PGL B 45 300 UNP P28907 CD38_HUMAN 45 300 SEQADV 2PGL LYS A 39 UNP P28907 CLONING ARTIFACT SEQADV 2PGL ARG A 40 UNP P28907 CLONING ARTIFACT SEQADV 2PGL GLU A 41 UNP P28907 CLONING ARTIFACT SEQADV 2PGL ALA A 42 UNP P28907 CLONING ARTIFACT SEQADV 2PGL GLU A 43 UNP P28907 CLONING ARTIFACT SEQADV 2PGL ALA A 44 UNP P28907 CLONING ARTIFACT SEQADV 2PGL THR A 49 UNP P28907 GLN 49 ENGINEERED MUTATION SEQADV 2PGL ASP A 100 UNP P28907 ASN 100 ENGINEERED MUTATION SEQADV 2PGL ASP A 164 UNP P28907 ASN 164 ENGINEERED MUTATION SEQADV 2PGL ASP A 209 UNP P28907 ASN 209 ENGINEERED MUTATION SEQADV 2PGL ASP A 219 UNP P28907 ASN 219 ENGINEERED MUTATION SEQADV 2PGL GLN A 226 UNP P28907 GLU 226 ENGINEERED MUTATION SEQADV 2PGL LYS B 39 UNP P28907 CLONING ARTIFACT SEQADV 2PGL ARG B 40 UNP P28907 CLONING ARTIFACT SEQADV 2PGL GLU B 41 UNP P28907 CLONING ARTIFACT SEQADV 2PGL ALA B 42 UNP P28907 CLONING ARTIFACT SEQADV 2PGL GLU B 43 UNP P28907 CLONING ARTIFACT SEQADV 2PGL ALA B 44 UNP P28907 CLONING ARTIFACT SEQADV 2PGL THR B 49 UNP P28907 GLN 49 ENGINEERED MUTATION SEQADV 2PGL ASP B 100 UNP P28907 ASN 100 ENGINEERED MUTATION SEQADV 2PGL ASP B 164 UNP P28907 ASN 164 ENGINEERED MUTATION SEQADV 2PGL ASP B 209 UNP P28907 ASN 209 ENGINEERED MUTATION SEQADV 2PGL ASP B 219 UNP P28907 ASN 219 ENGINEERED MUTATION SEQADV 2PGL GLN B 226 UNP P28907 GLU 226 ENGINEERED MUTATION SEQRES 1 A 262 LYS ARG GLU ALA GLU ALA ARG TRP ARG GLN THR TRP SER SEQRES 2 A 262 GLY PRO GLY THR THR LYS ARG PHE PRO GLU THR VAL LEU SEQRES 3 A 262 ALA ARG CYS VAL LYS TYR THR GLU ILE HIS PRO GLU MET SEQRES 4 A 262 ARG HIS VAL ASP CYS GLN SER VAL TRP ASP ALA PHE LYS SEQRES 5 A 262 GLY ALA PHE ILE SER LYS HIS PRO CYS ASP ILE THR GLU SEQRES 6 A 262 GLU ASP TYR GLN PRO LEU MET LYS LEU GLY THR GLN THR SEQRES 7 A 262 VAL PRO CYS ASN LYS ILE LEU LEU TRP SER ARG ILE LYS SEQRES 8 A 262 ASP LEU ALA HIS GLN PHE THR GLN VAL GLN ARG ASP MET SEQRES 9 A 262 PHE THR LEU GLU ASP THR LEU LEU GLY TYR LEU ALA ASP SEQRES 10 A 262 ASP LEU THR TRP CYS GLY GLU PHE ASP THR SER LYS ILE SEQRES 11 A 262 ASN TYR GLN SER CYS PRO ASP TRP ARG LYS ASP CYS SER SEQRES 12 A 262 ASN ASN PRO VAL SER VAL PHE TRP LYS THR VAL SER ARG SEQRES 13 A 262 ARG PHE ALA GLU ALA ALA CYS ASP VAL VAL HIS VAL MET SEQRES 14 A 262 LEU ASP GLY SER ARG SER LYS ILE PHE ASP LYS ASP SER SEQRES 15 A 262 THR PHE GLY SER VAL GLN VAL HIS ASN LEU GLN PRO GLU SEQRES 16 A 262 LYS VAL GLN THR LEU GLU ALA TRP VAL ILE HIS GLY GLY SEQRES 17 A 262 ARG GLU ASP SER ARG ASP LEU CYS GLN ASP PRO THR ILE SEQRES 18 A 262 LYS GLU LEU GLU SER ILE ILE SER LYS ARG ASN ILE GLN SEQRES 19 A 262 PHE SER CYS LYS ASN ILE TYR ARG PRO ASP LYS PHE LEU SEQRES 20 A 262 GLN CYS VAL LYS ASN PRO GLU ASP SER SER CYS THR SER SEQRES 21 A 262 GLU ILE SEQRES 1 B 262 LYS ARG GLU ALA GLU ALA ARG TRP ARG GLN THR TRP SER SEQRES 2 B 262 GLY PRO GLY THR THR LYS ARG PHE PRO GLU THR VAL LEU SEQRES 3 B 262 ALA ARG CYS VAL LYS TYR THR GLU ILE HIS PRO GLU MET SEQRES 4 B 262 ARG HIS VAL ASP CYS GLN SER VAL TRP ASP ALA PHE LYS SEQRES 5 B 262 GLY ALA PHE ILE SER LYS HIS PRO CYS ASP ILE THR GLU SEQRES 6 B 262 GLU ASP TYR GLN PRO LEU MET LYS LEU GLY THR GLN THR SEQRES 7 B 262 VAL PRO CYS ASN LYS ILE LEU LEU TRP SER ARG ILE LYS SEQRES 8 B 262 ASP LEU ALA HIS GLN PHE THR GLN VAL GLN ARG ASP MET SEQRES 9 B 262 PHE THR LEU GLU ASP THR LEU LEU GLY TYR LEU ALA ASP SEQRES 10 B 262 ASP LEU THR TRP CYS GLY GLU PHE ASP THR SER LYS ILE SEQRES 11 B 262 ASN TYR GLN SER CYS PRO ASP TRP ARG LYS ASP CYS SER SEQRES 12 B 262 ASN ASN PRO VAL SER VAL PHE TRP LYS THR VAL SER ARG SEQRES 13 B 262 ARG PHE ALA GLU ALA ALA CYS ASP VAL VAL HIS VAL MET SEQRES 14 B 262 LEU ASP GLY SER ARG SER LYS ILE PHE ASP LYS ASP SER SEQRES 15 B 262 THR PHE GLY SER VAL GLN VAL HIS ASN LEU GLN PRO GLU SEQRES 16 B 262 LYS VAL GLN THR LEU GLU ALA TRP VAL ILE HIS GLY GLY SEQRES 17 B 262 ARG GLU ASP SER ARG ASP LEU CYS GLN ASP PRO THR ILE SEQRES 18 B 262 LYS GLU LEU GLU SER ILE ILE SER LYS ARG ASN ILE GLN SEQRES 19 B 262 PHE SER CYS LYS ASN ILE TYR ARG PRO ASP LYS PHE LEU SEQRES 20 B 262 GLN CYS VAL LYS ASN PRO GLU ASP SER SER CYS THR SER SEQRES 21 B 262 GLU ILE HET N1C A 301 35 HETNAM N1C N1-CYCLIC INOSINE 5'-DIPHOSPHORIBOSE FORMUL 3 N1C C15 H20 N4 O14 P2 FORMUL 4 HOH *385(H2 O) HELIX 1 1 ARG A 58 HIS A 74 1 17 HELIX 2 2 PRO A 75 ARG A 78 5 4 HELIX 3 3 ASP A 81 ILE A 94 1 14 HELIX 4 4 THR A 102 ASP A 105 5 4 HELIX 5 5 TYR A 106 GLY A 113 1 8 HELIX 6 6 ILE A 128 VAL A 138 1 11 HELIX 7 7 THR A 144 ASP A 147 5 4 HELIX 8 8 THR A 148 ASP A 155 1 8 HELIX 9 9 ASN A 183 ALA A 200 1 18 HELIX 10 10 SER A 220 VAL A 225 1 6 HELIX 11 11 ASP A 252 GLN A 255 5 4 HELIX 12 12 ASP A 256 LYS A 268 1 13 HELIX 13 13 ARG A 280 ASN A 290 1 11 HELIX 14 14 ARG B 58 HIS B 74 1 17 HELIX 15 15 PRO B 75 ARG B 78 5 4 HELIX 16 16 ASP B 81 ILE B 94 1 14 HELIX 17 17 THR B 102 ASP B 105 5 4 HELIX 18 18 TYR B 106 GLY B 113 1 8 HELIX 19 19 ILE B 128 GLN B 139 1 12 HELIX 20 20 THR B 144 ASP B 147 5 4 HELIX 21 21 THR B 148 ASP B 155 1 8 HELIX 22 22 ASN B 183 ALA B 200 1 18 HELIX 23 23 SER B 220 VAL B 225 1 6 HELIX 24 24 GLN B 226 LEU B 230 5 5 HELIX 25 25 ASP B 252 GLN B 255 5 4 HELIX 26 26 ASP B 256 ARG B 269 1 14 HELIX 27 27 ARG B 280 ASN B 290 1 11 SHEET 1 A 2 GLY A 52 PRO A 53 0 SHEET 2 A 2 SER A 172 CYS A 173 -1 O CYS A 173 N GLY A 52 SHEET 1 B 4 LEU A 123 SER A 126 0 SHEET 2 B 4 ASP A 202 ASP A 209 1 O HIS A 205 N LEU A 124 SHEET 3 B 4 VAL A 235 ILE A 243 1 O TRP A 241 N VAL A 206 SHEET 4 B 4 GLN A 272 ILE A 278 1 O ILE A 278 N VAL A 242 SHEET 1 C 2 GLY B 52 PRO B 53 0 SHEET 2 C 2 SER B 172 CYS B 173 -1 O CYS B 173 N GLY B 52 SHEET 1 D 4 LEU B 123 SER B 126 0 SHEET 2 D 4 ASP B 202 ASP B 209 1 O HIS B 205 N LEU B 124 SHEET 3 D 4 VAL B 235 ILE B 243 1 O THR B 237 N VAL B 204 SHEET 4 D 4 GLN B 272 ILE B 278 1 O LYS B 276 N VAL B 242 SSBOND 1 CYS A 67 CYS A 82 1555 1555 2.11 SSBOND 2 CYS A 99 CYS A 180 1555 1555 2.08 SSBOND 3 CYS A 119 CYS A 201 1555 1555 2.11 SSBOND 4 CYS A 160 CYS A 173 1555 1555 2.11 SSBOND 5 CYS A 254 CYS A 275 1555 1555 2.11 SSBOND 6 CYS A 287 CYS A 296 1555 1555 2.04 SSBOND 7 CYS B 67 CYS B 82 1555 1555 2.10 SSBOND 8 CYS B 99 CYS B 180 1555 1555 2.10 SSBOND 9 CYS B 119 CYS B 201 1555 1555 2.04 SSBOND 10 CYS B 160 CYS B 173 1555 1555 2.14 SSBOND 11 CYS B 254 CYS B 275 1555 1555 2.07 SSBOND 12 CYS B 287 CYS B 296 1555 1555 2.05 SITE 1 AC1 18 LEU A 124 TRP A 125 SER A 126 ARG A 127 SITE 2 AC1 18 LEU A 145 GLU A 146 TRP A 189 SER A 193 SITE 3 AC1 18 SER A 220 THR A 221 PHE A 222 GLN A 226 SITE 4 AC1 18 HOH A 302 HOH A 334 HOH A 395 HOH A 417 SITE 5 AC1 18 HOH A 428 HOH A 474 CRYST1 41.866 53.195 65.706 105.79 92.07 95.20 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023886 0.002175 0.001523 0.00000 SCALE2 0.000000 0.018877 0.005436 0.00000 SCALE3 0.000000 0.000000 0.015848 0.00000